The diagnostic criteria for multiple sclerosis (MS) have been continuously evolved since
1950's, and gained speed parallel to the development of detailed laboratory methods. The …

Neuropsychiatric involvement of SLE includes a variety of symptoms that impact quality of
life and patient prognosis. There have been recent advances in improving the diagnosis of …

To address challenges in the diagnosis of cognitive dysfunction (CD) related to systemic
lupus erythematosus–associated (SLE-associated) autoimmune mechanisms rather than …

Study design issues related to patient selection (non-NPSLE vs. NPSLE syndromes, SLE
disease activity, medications) are critical for biomarker development. Regional and network …

Recent development of biologic disease-modifying anti-rheumatic drugs (DMARDs) has led
to better control of disease activity among patients with chronic rheumatological diseases …

Neuropsychiatric manifestations of systemic lupus erythematosus (SLE) are common and
frequently associated with a substantial negative impact on health outcomes. The …

Cognitive impairment (CI) frequently occurs in patients with systemic lupus erythematosus
(SLE) and may result from neuroinflammation processes and neurovascular changes in the …

Objective To review: 1) degree of conformity to the American College of Rheumatology
neuropsychological battery (ACR-NB) among studies that used a NB, 2) review definitions of …

To investigate core resting state networks in SLE patients with and without neuropsychiatric
symptoms by examining functional connectivity changes correlating with results of cognitive …

Introduction Systemic lupus erythematosus (SLE) is an autoimmune connective tissue
disease affecting multiple organs in the human body, including the central nervous system …